Presenting author
Simon Ward
2 presentations
DT-101 – a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator demonstrates favorable tolerability and functional biomarkers in phase 1 healthy volunteer trial
T65. DT-101 – a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator demonstrates favorable tolerability and functional biomarkers in phase 1 healthy volunteer trial